Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Procella Therapeutics logo — Procella Therapeutics develops cardiac stem cells for advanc...

Procella Therapeutics

Procella Therapeutics develops cardiac stem cells for advanced heart failure with a diverse multidisciplinary team.

Founded 2018 Sweden Sweden 40 employees Biotechnology, Health and Wellness

General Information

Company Name Procella Therapeutics
Founded Year 2018
Location Sweden Sweden +1
Employees 40
Industries Biotechnology, Health and Wellness
Social

Get notified when Procella Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Procella Therapeutics

Procella Therapeutics is a biotechnology startup based in Sweden with a mission to develop cardiac stem cells for advanced heart failure. The company, established in 2018, is at its preliminary stages but has already garnered attention due to its innovative approach. With a diverse multidisciplinary team, including experts in stem cell biology, bioprocess and analytical development, bioinformatics, and cardiology, Procella is well-positioned to make strides in the biotechnology industry. This emphasis on a team with varied expertise sets the company apart and puts it in a strong position for future growth and success. As Procella Therapeutics continues to advance its cardiac stem cell therapy, there is significant potential for it to attract investment and establish itself as a leader in addressing advanced heart failure.

Taxonomy: stem cell therapy, cardiac stem cells, heart failure, advanced heart failure, bioprocess development, analytical development, bioinformatics, cardiology, multidisciplinary team, preliminary stage, start-up, regenerative medicine

No funding data available for Procella Therapeutics yet.

Get notified when Procella Therapeutics raises funding

FAQ About Procella Therapeutics

Procella Therapeutics develops cardiac stem cells for advanced heart failure with a diverse multidisciplinary team.
Procella Therapeutics was founded in 2018.
Procella Therapeutics is headquartered in Sweden.
Procella Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Procella Therapeutics has approximately 40 employees.

We're actively collecting intelligence on Procella Therapeutics.

Track Procella Therapeutics to get notified

Don't just browse. Track.

Signal Tracker monitors Procella Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy